EUVIMEDEUVIMED entdecken
Leitlinie

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

Paul E Sax, Melanie A Thompson, Michael S Saag, IAS-USA Treatment Guidelines Panel

JAMA · 2024

DOI: 10.1001/jama.2024.2985 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, 2024. Verfasst von Paul E Sax und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rajesh T. Gandhi, MD; Roger Bedimo, MD; Jennifer F. Hoy, MBBS; Raphael J. Landovitz, MD; Davey M. Smith, MD; Ellen F. Eaton, MD; Clara Lehmann, MD; Sandra A. Springer, MD; Paul E. Sax, MD; Melanie A. Thompson, MD; Constance A. Benson, MD; Susan P. Buchbinder, MD; Carlos del Rio, MD; Joseph J. Eron Jr, MD; Huldrych F. Günthard, MD; Jean-Michel Molina, MD; Donna M. Jacobsen, BS; Michael S. Saag, MD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsHumansAnti-Retroviral AgentsDiketopiperazinesPyridonesRilpivirineHIV Integrase InhibitorsUnited StatesPractice Guidelines as Topic

Substanzen

Anti-HIV AgentsAnti-Retroviral AgentscabotegravirDiketopiperazinesPyridonesRilpivirineHIV Integrase Inhibitors

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • AIDS Research Consortium of Atlanta, Atlanta, Georgia.
  • School of Medicine, University of Alabama at Birmingham.

Zitieren

APA

Sax, P. E., Thompson, M. A., Saag, M. S., & IAS-USA Treatment Guidelines Panel (2024). Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel. JAMA. https://doi.org/10.1001/jama.2024.2985

Vancouver

Sax PE, Thompson MA, Saag MS, IAS-USA Treatment Guidelines Panel. Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel. JAMA. 2024. doi:10.1001/jama.2024.2985

BibTeX
@article{Sax2024,
  author = {Sax, Paul E and Thompson, Melanie A and Saag, Michael S and IAS-USA Treatment Guidelines Panel, IAS-USA Treatment Guidelines Panel},
  title = {Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.2985}
}
Kostenlos starten →